Addus HomeCare Corp is engaged in the provision of in-home care services... Show more
Addus HomeCare is one of the largest U.S. providers of in-home personal care, hospice, and home health services, with revenue tied heavily to government reimbursement programs such as Medicaid and Medicare. Its third quarter 2026 report matters because it shows whether demand for aging-in-place care remains resilient and whether the company can convert that demand into margin expansion. The results arrive against a backdrop of consolidation, highlighted by Addus's September 2026 agreement to acquire AccentCare's personal care division for roughly $275 million. Investors were watching whether organic growth held up ahead of that integration, making this quarter an important signal of the company's underlying momentum and cost discipline.
For the third quarter ended September 30, 2026, Addus HomeCare reported net service revenue of $387.7 million, an increase of 7.0% from $362.3 million in the prior-year period but narrowly below the $388.70 million consensus. GAAP net income rose to $28.6 million, or $1.54 per diluted share, compared with $22.8 million, or $1.24 per share, a year earlier.
On a non-GAAP basis, adjusted EPS climbed 17.3% year over year to $1.83, exceeding the $1.79 analyst estimate by $0.04. Adjusted EBITDA grew 13.5% to $51.2 million from $45.1 million, outpacing revenue growth and reflecting operating leverage. Cash flow from operations was $40.9 million for the quarter.
By segment, personal care contributed 77.6% of revenue and posted 6.9% organic growth, supported by volume expansion and the HomeCourt Home Care acquisition. Hospice represented 17.8% of revenue with a 4.3% organic increase in average daily census, or 8.8% excluding a prior-year benefit. Home health, at 4.6% of revenue, returned to year-over-year organic growth.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like Addus HomeCare or seeking new setups across the healthcare sector, the AI Screener offers a streamlined way to identify candidates aligned with specific criteria.
Addus HomeCare shares closed at $126.20 and fell about 2.6% in after-hours trading following the release. The reaction reflected a mixed read: the adjusted EPS beat by $0.04 was overshadowed by revenue that came in slightly below consensus. With the stock up more than 12% over the prior twelve months, investors appeared focused on whether top-line momentum could keep pace with the company's profitability gains. The modest revenue miss, though narrow, was enough to prompt some profit-taking, even as segment-level organic growth and margin expansion remained broadly healthy across personal care, hospice, and home health.
The most significant catalyst ahead is the closing and integration of the AccentCare personal care division acquisition, announced in September 2026. The deal is expected to add roughly $280 million in annualized revenue, expanding the company's revenue base by nearly 19%, while strengthening its presence in Texas, Illinois, California, and Arizona. Investors will watch for the timing of regulatory approvals and any update on integration costs or synergy assumptions.
Beyond the acquisition, key factors to monitor include reimbursement rate trends across core states, the pace of organic census and billable-hour growth, and the sustainability of margin expansion as the company absorbs a larger workforce. Labor availability and caregiver hiring costs remain central to profitability in a business driven by personal care hours.
Home health volumes, which have been more volatile, will also be worth tracking as management works to sustain the segment's return to organic growth. As always with Addus HomeCare, government payment policy and state-level Medicaid dynamics can shift demand and pricing, making reimbursement updates an ongoing watch item for the quarters ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of home and community based services
Industry HospitalNursingManagement